Skip to main content
OpenTrials

Clinical trial condition

Paramyxoviridae Infections

Explore clinical trials studying Paramyxoviridae Infections. Study availability and eligibility vary by location and protocol.

354 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Paramyxoviridae Infections trial results

Completed

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

NCT02135614

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Anne Arundel Medical Center Annapolis, Maryland, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • William Beaumont Royal Oak, Michigan, United States
View all 43 locations
View Trial Details
Completed

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age

NCT02794870

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program La Jolla, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • Univ. of Colorado Denver NICHD CRS Aurora, Colorado, United States
  • Rush Univ. Cook County Hosp. Chicago NICHD CRS Chicago, Illinois, United States
View Trial Details
Completed

Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children

NCT01506193

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations
  • GSK Investigational Site Rome, Lazio, Italy
  • GSK Investigational Site Chiavari, Liguria, Italy
  • GSK Investigational Site Genoa, Liguria, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
View all 13 locations
View Trial Details
Completed

Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women

NCT02360475

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Lenexa, Kansas, United States
  • GSK Investigational Site Lexington, Kentucky, United States
View Trial Details

Related conditions